[artículo] 
inJournal of the American Academy of Child & Adolescent Psychiatry > Año 2017 - Vol.56 - No.8 [25/09/2017] . - pp. 642-651

Título :	Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus
Tipo de documento:	texto impreso
Autores:	Mehmet Burcu, Autor ; Julie M. Zito, Autor
Fecha de publicación:	2017
Artículo en la página:	pp. 642-651
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Diabetes Mellitus Tipo 2, Antipsicóticos Atípicos, Antidepresivos, Estimulantes, Medicaid.
Resumen:	More than half of youth treated with atypical antipsychotic (AAP) medications are also treated with concomitant antidepressants or stimulants. This study assessed the association between antidepressant or stimulant use concomitant with AAPs and the risk of incident type 2 diabetes mellitus (T2DM).
Link:	./index.php?lvl=notice_display&id=9590

[artículo] Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus [texto impreso] / Mehmet Burcu, Autor ; Julie M. Zito, Autor . - 2017 . - pp. 642-651.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2017 - Vol.56 - No.8 [25/09/2017] . - pp. 642-651

Palabras clave:	Diabetes Mellitus Tipo 2, Antipsicóticos Atípicos, Antidepresivos, Estimulantes, Medicaid.
Resumen:	More than half of youth treated with atypical antipsychotic (AAP) medications are also treated with concomitant antidepressants or stimulants. This study assessed the association between antidepressant or stimulant use concomitant with AAPs and the risk of incident type 2 diabetes mellitus (T2DM).
Link:	./index.php?lvl=notice_display&id=9590